Clinical trial
Effectiveness of Generic Cetrorelix Acetate Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a GnRH Antagonist Protocol in Women Undergoing IVF: A Multicenter Non-inferiority, Randomised Controlled Trial
NCT06023602 is registered in ClinicalTrials.gov with Northwest Women's and Children's Hospital, Xi'an, Shaanxi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Generic Cetrorelix Acetate Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a GnRH Antagonist Protocol in Women Undergoing IVF: A Multicenter Non-inferiority, Randomised Controlled Trial
- Lead sponsor
- Northwest Women's and Children's Hospital, Xi'an, Shaanxi
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 27, 2024
- Completion date
- December 1, 2025
- Enrollment
- 1,338 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.